Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study evaluating ASP1941 in Asian subjects with Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
The clinical trial evaluating the feasibility and acceptability of a remote glucose monitoring program for pregnant Marshallese women has be…
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: The Clinical Impact of Diet on Medical Conditions Treated Within Bundled Payment Models: a Pilot Study [NA]
A pilot clinical trial evaluating the impact of diet on conditions treated under bundled payment models has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-25Clinical Trial Update: A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease [Phase 3]
Prokidney's Phase 3 study of Renal Autologous Cell Therapy (REACT) for type 2 diabetes mellitus and chronic kidney disease has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Polypill Versus Metformin in New Onset Type 2 Diabetes [Phase 2]
A Phase 2 trial comparing a polypill with metformin for new-onset Type 2 diabetes mellitus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Diabetes Self-Management Education with Sleep Hygiene [NA]
The University of Arkansas trial on diabetes mellitus type 2 self-management education with sleep hygiene has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-28Clinical Trial Update: Lifestyle Intervention in Obesity, Effect on Diabetes
A clinical trial evaluating the impact of lifestyle intervention for obesity on Type 2 Diabetes has been withdrawn from the study registry.
-
CLINICAL_TRIALS withdrawal · 2024-08-23Clinical Trial Update: An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake. [NA]
A clinical trial evaluating a meal-replacement shake for quality of life in individuals with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-23Clinical Trial Update: Program AACTIVE: African Americans Coming Together to Increase Vital Exercise [NA]
A clinical trial titled Program AACTIVE evaluating an exercise program for African Americans with Type 2 Diabetes and Depression has been wi…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema [Phase 3]
A Phase 3 trial evaluating intravitreal bevacizumab for diffuse diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population [Phase 3]
A Phase 3 clinical trial investigating HLA and its relation to the development of proliferative diabetic retinopathy in Mexican patients wit…
-
CLINICAL_TRIALS withdrawal · 2024-05-29Clinical Trial Update: The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial assessing the effects of alpha-lipoic acid on glycemic control in type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-28Clinical Trial Update: Effectiveness of an Online Self-management Intervention for Type 2 Diabetes Mellitus [NA]
A clinical trial evaluating an online self-management intervention for Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Improving Mental Health in Diabetes: A Guided Self-Help Study [NA]
A University of Edinburgh clinical trial investigating guided self-help for mental health in people with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Empagliflozin Effect on Glucose Toxicity [Phase 4]
A Phase 4 trial evaluating empagliflozin for glucose toxicity in type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-02-26Clinical Trial Update: Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial comparing semaglutide tablets with empagliflozin or metformin in adults with type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial of Atenas Association for Type II diabetes mellitus and hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial investigating Egito Association for Type II diabetes mellitus and hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-08-15Clinical Trial Update: Pioglitazone and Insulin Resistance in ADT [Phase 3]
Phase 3 trial evaluating pioglitazone for insulin resistance in the context of androgen deprivation therapy for prostate cancer has been wit…
-
EMA withdrawal · 2023-05-04EMA Withdrawn: Pioglitazone Teva (pioglitazone hydrochloride) — Teva B.V.
Pioglitazone Teva (pioglitazone hydrochloride) has been withdrawn from the European market.
-
CLINICAL_TRIALS withdrawal · 2022-11-29Clinical Trial Update: Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes [Phase 4]
A Phase 4 trial of vortioxetine monotherapy for major depressive disorder in patients with type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-11-14Clinical Trial Update: Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity [Phase 3]
A Phase 3 clinical trial comparing semaglutide tablets with empagliflozin tablets for type 2 diabetes and obesity was withdrawn.
-
EMA withdrawal · 2022-10-18EMA Withdrawn: Glubrava (metformin hydrochloride;pioglitazone hydrochloride) — Takeda Pharma A/S
Glubrava, a fixed-dose combination of metformin hydrochloride and pioglitazone hydrochloride, has been withdrawn from the market.
-
EMA withdrawal · 2022-10-17EMA Withdrawn: Glustin (pioglitazone hydrochloride) — Takeda Pharma A/S
EMA has withdrawn Glustin (pioglitazone hydrochloride) from the market.
-
EMA withdrawal · 2022-10-17EMA Withdrawn: Glidipion (previously Pioglitazone Actavis Group) (pioglitazone hydrochloride) — Actavis Group PTC ehf
The EMA has withdrawn Glidipion (pioglitazone hydrochloride) from the market.